IP Library Assignment 025095/0479
Patent Assignment
Reel/Frame 025095/0479

Release of Security Agreement

Recorded: 2010-10-06 Received: 2010-10-06 Pages: 46
Assignor
Assignees
BIOVAIL CORPORATION
7150 MISSISSAUGA ROAD, MISSISSAUGA, ONTARIO, CAX, L5N 8M5, CANADA
BIOVAIL LABORATORIES INTERNATIONAL SRL
7150 MISSISSAUGA ROAD, MISSISSAUGA, ONTARIO, CAX, L5N 8M5, CANADA
Covered Properties (30)
Pharmaceutical Compositions
Application: 12/360,673 →
Controlled Release Dosage Forms
Application: 12/328,828 →
Controlled Release Dosage Forms
Application: 12/169,852 →
Modified-Release Formulations of a Bupropion Salt
Application: 11/993,723 →
Chronotherapeutic Diltiazem Formulations and the Administration Thereof
Application: 11/952,343 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/930,644 →
Modified Release Formulations of at Least One Form of Tramadol
Application: 11/928,908 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/834,848 →
Modified Release Formulations of a Bupropion Salt
Application: 11/774,109 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,213 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,251 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,239 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,840 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,820 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,368 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,343 →
Modified Release Formulations of a Bupropion Salt
Application: 11/759,413 →
Modified Release Formulations Of Selective Serotonin Re-Uptake Inhibitors
Application: 10/556,492 →
Modified Release Formulations of a Bupropion Salt
Application: 11/755,946 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,785 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,768 →
Modified Release Formulations of a Bupropion Salt
Application: 11/475,252 →
Modified Release Tablet of Bupropion Hydrochloride
Application: 11/451,496 →
Modified release formulations of at least one form of tramadol
Application: 10/517,809 →
Modified Release Compositions of at Least One Form of Tramadol
Application: 10/933,479 →
Extended release pharmaceutical tablet of metformin
Application: 10/771,987 →
Chronotherapeutic Diltiazem Formulations and the Administration Thereof
Application: 10/657,752 →
Controlled Release Dosage Forms
Application: 10/370,109 →
Extended release pharmaceutical tablet of metformin
Application: 10/309,193 →
Extended Release Metformin Hydrochloride Formulations
Application: 09/845,496 →